Dr. Scott Kopetz discusses the BREAKWATER trial investigating Braftovi and Erbitux plus chemo in those with BRAF V600E+ metastatic colorectal cancer. Dr. Susumu Hijioka spoke about the benefit of this ...
Ok, as if our January TV schedules couldn't get any better ... we've seen Giselle enter into a feud with fellow employee Jordyn Taylor Braf, after she 'nabbed' the high-profile buyer of a 20 ...
The BRAF Inhibitors market is expected to grow significantly in the coming years. This is due to the increasing number of patients being diagnosed with cancer, rise in biomarker testing rates, the ...
Immuneering plans to expand phase 2a trials with new combination arms, targeting BRAF-mutant melanoma and non-small cell lung cancer. A phase 2a trial of IMM-1-104 plus chemotherapy demonstrated ...
We've searched high and low for this week's best TV deals, which means you'll find all the best offers to kick off 2025 on this page. We've weeded out the offers that aren't worth your time ...
This new study is expected to initiate in early 2026. CFT1946: CFT1946 is an oral degrader targeting BRAF V600 mutations for the potential treatment of solid tumors including colorectal cancer (CRC), ...
The TCL S4 4K TV makes a great value play for your viewing area. It produces a great 4K picture with high dynamic range capability, and it comes with a voice remote for convenient navigation and ...
These therapies focus on specific genetic mutations or molecular drivers, such as EGFR, ALK, ROS1, BRAF, and MET, which are commonly implicated in NSCLC. Drugs targeting these mutations ...
Here’s how it works. Today's TV deals can make buying a new 4K TV more affordable than ever. I've been tracking TV deals for over a decade and I know how to spot a good deal from a mediocre ...
A 55-inch 4K TV is a good size to suit most rooms, and the Insignia F30 has almost everything you could hope for in a TV this size. It presents all of your favorite content in breathtaking 4K ...
But I don't feel like my patients colorectal cancer know if they have like a KRAS mutation or not or a BRAF mutation or not. So there is a huge gap here. And of course, the only way to fill this ...